ArriVent is a US-based biopharma company dedicated to accelerating the global development of innovative biopharmaceutical products.
Location: United States, Pennsylvania, Newtown Township
Total raised: $415M
Investors 5
Date | Name | Website |
- | Octagon Ca... | octagoninv... |
14.04.2023 | Sofinnova ... | sofinnova.... |
- | OrbiMed | orbimed.co... |
05.06.2023 | HBM Partne... | hbmpartner... |
- | Catalio Ca... | cataliocap... |
Funding Rounds 3
Date | Series | Amount | Investors |
28.03.2023 | Series B | $155M | - |
28.12.2022 | Series B | $110M | - |
03.07.2021 | - | $150M | Octagon Ca... |
Mentions in press and media 10
Date | Title | Description | Source |
26.01.2024 | ArriVent’s Nasdaq Debut Nabs $175M as Signs Indicate an Open... | Cancer drug developer ArriVent BioPharma has a lead program with the potential to treat lung cancers... | medcitynew... |
28.03.2023 | Ad hoc announcement pursuant to Art. 53 LRHBM Healthcare Inv... | HBM Healthcare Investments refers to its media release dated 30 January 2023. Dr Andreas Wicki has r... | hbmhealthc... |
27.03.2023 | ArriVent Biopharma Closes $155M in Series B Financing | ArriVent Biopharma, a Newtown Square, PA-based company dedicated to accelerating the global developm... | finsmes.co... |
27.03.2023 | ArriVent Biopharma Closes $155 Million Oversubscribed Series... | - | globenewsw... |
27.03.2023 | ArriVent Biopharma Closes $155M Series B Financing | NEWTOWN SQUARE, PA, ArriVent Biopharma announces $155M oversubscribed Series B financing led by So... | vcnewsdail... |
27.03.2023 | ArriVent Biopharma Closes $155 Million Oversubscribed Series... | - | sofinnova.... |
05.01.2023 | Monday Moves: 3 Philly biotech companies are starting 2023 w... | Money Moves is a column where we chart the funding raises of tech companies across the region. Have ... | technical.... |
30.06.2021 | ArriVent raises $150M to bring Chinese drugs to Western mark... | ArriVent Biopharma has raised up to $150 million to in-license assets from China and other emerging ... | fiercebiot... |
- | Biopharmaceutical Therapeutics Company ArriVent Biopharma Ra... | ArriVent Biopharma is raising $155 million in funding. ArriVent Biopharma – a company dedicated to a... | pulse2.com... |
- | ArriVent Biopharma | “Leveraging Global Discoveries, Arrivent Biopharma is Building a Unique Handpicked Pipeline Grounded... | fastfounde... |